Robert M Kunemund
Examiner (ID: 4089)
Most Active Art Unit | 1714 |
Art Unit(s) | 1107, 1765, 1714, 1792, 1722, 1109, 1103, 1763 |
Total Applications | 3442 |
Issued Applications | 2671 |
Pending Applications | 149 |
Abandoned Applications | 593 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16589302
[patent_doc_number] => 10898544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Polypeptides for managing viral infections
[patent_app_type] => utility
[patent_app_number] => 16/469119
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 41
[patent_no_of_words] => 23788
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469119 | Polypeptides for managing viral infections | Nov 30, 2017 | Issued |
Array
(
[id] => 13300251
[patent_doc_number] => 20180201662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => PEPTIDE FOR PROMOTING CELL MIGRATION AND/OR SKIN WOUND HEALING, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/826159
[patent_app_country] => US
[patent_app_date] => 2017-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15826159
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/826159 | PEPTIDE FOR PROMOTING CELL MIGRATION AND/OR SKIN WOUND HEALING, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND APPLICATION THEREOF | Nov 28, 2017 | Abandoned |
Array
(
[id] => 12239910
[patent_doc_number] => 20180072773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'CANCER STEM CELL TARGETING PEPTIDE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/820825
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5647
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15820825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/820825 | Cancer stem cell targeting peptide and use thereof | Nov 21, 2017 | Issued |
Array
(
[id] => 12260595
[patent_doc_number] => 20180079792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'PEPTIDE HAVING EIGHT AMINO ACID SEQUENCES DERIVED FROM CAGE AND RETAINING ANTICANCER ACTIVITY AND ACTIVITY TO PROMOTE ANTICANCER DRUG SENSITIVITY OF ANTICANCER DRUG-RESISTANT CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/815780
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4004
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/815780 | Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells | Nov 16, 2017 | Issued |
Array
(
[id] => 13457761
[patent_doc_number] => 20180280423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => COMPOSITIONS AND METHODS FOR COMBATING DRUG-RESISTANT CANCERS
[patent_app_type] => utility
[patent_app_number] => 15/812463
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -63
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15812463
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/812463 | Compositions and methods for combating drug-resistant cancers | Nov 13, 2017 | Issued |
Array
(
[id] => 14808361
[patent_doc_number] => 20190270790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => THERAPEUTIC FOR THE PREVENTION AND/OR TREATMENT OF WEIGHT GAIN AND/OR DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/348443
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348443 | Therapeutic for the prevention and/or treatment of weight gain and/or diabetes | Nov 8, 2017 | Issued |
Array
(
[id] => 16204860
[patent_doc_number] => 20200237850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Medical Preparation and Method for Enhancing Tissue Oxygenation in Case of Diabetic Foot
[patent_app_type] => utility
[patent_app_number] => 16/634973
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634973
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634973 | Medical preparation and method for enhancing tissue oxygenation in case of diabetic foot | Nov 7, 2017 | Issued |
Array
(
[id] => 12706906
[patent_doc_number] => 20180127468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => ANTI-HIV PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/805933
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15805933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/805933 | Anti-HIV peptides | Nov 6, 2017 | Issued |
Array
(
[id] => 14552631
[patent_doc_number] => 10344765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Stable liquid formulation of AMG 416 (etelcalcetide)
[patent_app_type] => utility
[patent_app_number] => 15/802390
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 12649
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802390
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/802390 | Stable liquid formulation of AMG 416 (etelcalcetide) | Nov 1, 2017 | Issued |
Array
(
[id] => 14833083
[patent_doc_number] => 20190274942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => NOVEL PEPTIDE AND COSMETIC COMPOSITION FOR INHIBITING SKIN AGING OR SKIN WRINKLE FORMATION, CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 16/345888
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345888
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345888 | Method of facilitating the bindings between keratinocytes | Oct 29, 2017 | Issued |
Array
(
[id] => 12231932
[patent_doc_number] => 20180064795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'HLA-A* 1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/796368
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8526
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796368 | HLA-A* 1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Oct 26, 2017 | Abandoned |
Array
(
[id] => 15083233
[patent_doc_number] => 20190336427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => NOVEL PROTEIN TRANSDUCTION DOMAIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/346373
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346373 | NOVEL PROTEIN TRANSDUCTION DOMAIN AND USE THEREOF | Oct 25, 2017 | Abandoned |
Array
(
[id] => 14808825
[patent_doc_number] => 20190271022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => Signal Polypeptide For Improved Secretion Of Protein
[patent_app_type] => utility
[patent_app_number] => 16/344993
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344993
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344993 | Signal Polypeptide For Improved Secretion Of Protein | Oct 25, 2017 | Abandoned |
Array
(
[id] => 16913976
[patent_doc_number] => 20210187068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Lipopolysaccharide-Binding Protein For Use In A Method Of Treating Alzheimer's Disease
[patent_app_type] => utility
[patent_app_number] => 16/640039
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640039 | Lipopolysaccharide-binding protein for use in a method of treating alzheimer's disease | Oct 3, 2017 | Issued |
Array
(
[id] => 14132331
[patent_doc_number] => 20190100555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => EYE-CARE PEPTIDE, ITS COMPOSITION AND METHOD OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/722522
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15722522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/722522 | Eye-care peptide, its composition and method of using the same | Oct 1, 2017 | Issued |
Array
(
[id] => 16492383
[patent_doc_number] => 10858408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Transdermal peptide with nuclear localization ability and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/484153
[patent_app_country] => US
[patent_app_date] => 2017-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3784
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484153
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484153 | Transdermal peptide with nuclear localization ability and use thereof | Sep 29, 2017 | Issued |
Array
(
[id] => 14130153
[patent_doc_number] => 20190099466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => PEPTIDE FOR PROMOTING WOUND HEALING, ITS COMPOSITION AND METHOD OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/720767
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15720767
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/720767 | Peptide for promoting wound healing, its composition and method of using the same | Sep 28, 2017 | Issued |
Array
(
[id] => 16041071
[patent_doc_number] => 10682386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Compositions for prevention of adhesions and other barrier applications
[patent_app_type] => utility
[patent_app_number] => 15/716262
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25456
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15716262
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/716262 | Compositions for prevention of adhesions and other barrier applications | Sep 25, 2017 | Issued |
Array
(
[id] => 16326833
[patent_doc_number] => 20200297798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => KEY AMINO ACID SITES REGULATING NUCLEAR EXPORT OF NUCLEOPROTEIN IN INFLUENZA A AND B VIRUSES AND USE THEREOF AS ANTI-INFLUENZA VIRUS DRUG TARGETS
[patent_app_type] => utility
[patent_app_number] => 16/645227
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645227 | KEY AMINO ACID SITES REGULATING NUCLEAR EXPORT OF NUCLEOPROTEIN IN INFLUENZA A AND B VIRUSES AND USE THEREOF AS ANTI-INFLUENZA VIRUS DRUG TARGETS | Sep 21, 2017 | Abandoned |
Array
(
[id] => 12138218
[patent_doc_number] => 20180016302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'Peptides for Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 15/706942
[patent_app_country] => US
[patent_app_date] => 2017-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13001
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15706942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/706942 | Methods for treating cancer | Sep 17, 2017 | Issued |